Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Cd68em1flox/Cya
Common Name:
Cd68-flox
Product ID:
S-CKO-01636
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cd68-flox
Strain ID
CKOCMP-12514-Cd68-B6N-VA
Gene Name
Cd68
Product ID
S-CKO-01636
Gene Alias
Lamp4; Scard1; gp110
Background
C57BL/6NCya
NCBI ID
12514
Modification
Conditional knockout
Chromosome
11
Phenotype
MGI:88342
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Cd68em1flox/Cya mice (Catalog S-CKO-01636) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000018918
NCBI RefSeq
NM_001291058
Target Region
Exon 1~6
Size of Effective Region
~1.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Cd68, also known as CD68 molecule, plays a critical role in promoting phagocytosis. Macrophages and other cells can express the CD68 antigen [5]. It is involved in the regulation of immune responses and has been associated with inflammation-related processes [5,6]. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, could potentially be valuable in further elucidating its functions in vivo.

In various cancers, CD68 shows significant associations. In gastric cancer, higher infiltration of SPI1+CD68+ tumor-associated macrophages (TAMs) is related to poor overall survival, and SPI1 in these macrophages promotes M2-type macrophage polarization and angiogenesis, suggesting it as a biomarker for prognosis and a target for combined anti-angiogenic and immunotherapy [1]. In Hodgkin's lymphoma, increased infiltration of CD68+ macrophages correlates with poor prognosis, as they support the survival of Reed Sternberg Cells [2]. In glioma, TIM-3/CD68 double-high expression indicates poor survival and may be a new marker, and exploring the combination of TIM-3 inhibitors and p38 MAPK inhibitor could be a treatment direction [3]. In pan-cancer analysis, CD68 levels vary in different cancer types, with high levels correlating with adverse prognosis in some cancers like glioblastoma and favorable prognosis in kidney chromophobe, and inhibiting CD68-dependent signaling could be a therapeutic strategy [4]. In non-small cell lung cancer (NSCLC), high infiltration of CD68+SHP2+ TAMs predicts poor overall survival, and targeting SHP2 may inhibit M2-phenotype polarization [7]. In hepatocellular carcinoma, a meta-analysis showed that CD68+ TAMs are significantly associated with unfavorable overall survival and disease-free survival, suggesting it as a prognostic biomarker [8]. In intracranial aneurysms, there may be an involvement of CD68 in aneurysm development but not rupture, and its expression in the aneurysmal wall is associated with aneurysm size [5,6].

In conclusion, Cd68 is involved in immune-related functions, especially in the context of tumor-associated macrophages across multiple cancer types, where it can influence prognosis and potentially serve as a biomarker or therapeutic target. In intracranial aneurysms, it may be related to the development rather than rupture. Studies using KO or CKO mouse models could further clarify its roles in these disease conditions.

References:
1. Deng, Guofei, Wang, Pengliang, Su, Rishun, Zhang, Changhua, Yin, Songcheng. 2024. SPI1+CD68+ macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2024-009983. https://pubmed.ncbi.nlm.nih.gov/39455096/
2. Tomarchio, Valeria, Rigacci, Luigi. 2023. Role of CD68 in the tumor immune microenvironment in Hodgkin's lymphoma. In Expert review of clinical immunology, 20, 811-819. doi:10.1080/1744666X.2023.2294943. https://pubmed.ncbi.nlm.nih.gov/38087440/
3. Hu, Wanming, Li, Depei, Yang, Yuanzhong, Zeng, Jing, Sai, Ke. 2024. TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approaches. In International immunopharmacology, 139, 112665. doi:10.1016/j.intimp.2024.112665. https://pubmed.ncbi.nlm.nih.gov/39002523/
4. Zhang, Jingwei, Li, Shuwang, Liu, Fangkun, Yang, Kui. 2022. Role of CD68 in tumor immunity and prognosis prediction in pan-cancer. In Scientific reports, 12, 7844. doi:10.1038/s41598-022-11503-2. https://pubmed.ncbi.nlm.nih.gov/35550532/
5. Rahmanian, Abdolkarim, Salehi, Ahmad, Kamali-Sarvestani, Eskandar, Jamali, Mohammad, Ghahramani, Sulmaz. 2023. CD68 Antigen and Cerebral Aneurysms: A Case-Control Study. In Journal of neurological surgery. Part A, Central European neurosurgery, 85, 142-146. doi:10.1055/s-0043-1761944. https://pubmed.ncbi.nlm.nih.gov/36828013/
6. Crusius, Cassiano Ughini, Cambruzzi, Eduardo, Crusius, Marcelo Ughini, Crusius, Paulo Sérgio, Stefani, Marco Antônio. 2023. CD68 in Cerebral Aneurysms of Smokers and Nonsmokers: An Immunohistochemical Analysis. In Journal of neurological surgery. Part A, Central European neurosurgery, 85, 555-560. doi:10.1055/a-2155-2166. https://pubmed.ncbi.nlm.nih.gov/37586409/
7. Liu, Xu, Zhang, Zengfu, Yuan, Jupeng, Yu, Jinming, Chen, Dawei. 2024. Spatial interaction and functional status of CD68+SHP2+ macrophages in tumor microenvironment correlate with overall survival of NSCLC. In Frontiers in immunology, 15, 1396719. doi:10.3389/fimmu.2024.1396719. https://pubmed.ncbi.nlm.nih.gov/38799432/
8. Jin, Danwen, Qian, Liyong, Chen, Jiayao, Yu, Ze, Dong, Jinliang. . Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis. In Medicine, 103, e37834. doi:10.1097/MD.0000000000037834. https://pubmed.ncbi.nlm.nih.gov/38640338/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest